US Drug Recall Register
Class II · Moderate risk Terminated Initiated Sep 23, 2015 (11 years ago)

Sermorelin 6mg/6mL Lyophilized Powder, Sterile Compound for Subcutaneous Injection…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a lack of sterility assurance.

What was recalled

Sermorelin 6mg/6mL Lyophilized Powder, Sterile Compound for Subcutaneous Injection, Diabetes Corporation of America dba DCA Pharmacy, Franklin, TN 37064-5527

Recalling firm
Diabetes Corporation of America dba DCA Pharmacy
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0006-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Sermorelin recalls

See all